| Product NDC: | 13537-442 |
| Proprietary Name: | esika |
| Non Proprietary Name: | OCTINOXATE and Oxybenzone |
| Active Ingredient(s): | .073; .0165 g/g; g/g & nbsp; OCTINOXATE and Oxybenzone |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | LIPSTICK |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 13537-442 |
| Labeler Name: | Ventura Corporation LTD. |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part352 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20121206 |
| Package NDC: | 13537-442-02 |
| Package Description: | 1 TUBE in 1 BOX (13537-442-02) > 4 g in 1 TUBE (13537-442-01) |
| NDC Code | 13537-442-02 |
| Proprietary Name | esika |
| Package Description | 1 TUBE in 1 BOX (13537-442-02) > 4 g in 1 TUBE (13537-442-01) |
| Product NDC | 13537-442 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | OCTINOXATE and Oxybenzone |
| Dosage Form Name | LIPSTICK |
| Route Name | TOPICAL |
| Start Marketing Date | 20121206 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | Ventura Corporation LTD. |
| Substance Name | OCTINOXATE; OXYBENZONE |
| Strength Number | .073; .0165 |
| Strength Unit | g/g; g/g |
| Pharmaceutical Classes |